USANA Health Sciences, Inc.
General ticker "USNA" information:
- Sector: Consumer Staples
- Industry: Packaged Foods
- Capitalization: $432.2M (TTM average)
USANA Health Sciences, Inc. does not follow the US Stock Market performance with the rate: -19.6%.
Estimated limits based on current volatility of 3.1%: low 18.96$, high 20.17$
Factors to consider:
- Total employees count: 1700 (-5.6%) as of 2024
- China accounted for 48.4% of revenue in the fiscal year ended 2024-12-28
- US accounted for 10.7% of revenue in the fiscal year ended 2024-12-28
- Top business risk factors: Manufacturing disruptions, Cybersecurity threats, Geopolitical risks, Economic downturns and volatility, Product liability
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-03 to 2028-01-03
- 2026-01-03 to 2027-01-03 estimated range: [16.29$, 28.25$]
- 2027-01-03 to 2028-01-03 estimated range: [16.34$, 27.93$]
Financial Metrics affecting the USNA estimates:
- Positive: with PPE of 10.3 at the end of fiscal year the price was neutral
- Positive: -5.39 < Operating profit margin, % of 4.05
- Positive: -9.55 < Industry operating profit margin (median), % of 0.89
- Negative: Shareholder equity ratio, % of 71.76 > 64.29
- Negative: 0 < Industry inventory ratio change (median), % of 0.26
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of 1.52
- Negative: Industry operating cash flow per share per price (median), % of 4.29 <= 5.46
- Positive: -0.02 < Operating cash flow per share per price, % of 6.07
- Negative: 0.01 < Interest expense per share per price, % of 0.23
Short-term USNA quotes
Long-term USNA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-28 | 2026-01-03 |
|---|---|---|---|
| Operating Revenue | $921.01MM | $854.50MM | $925.26MM |
| Operating Expenses | $827.94MM | $788.18MM | $887.83MM |
| Operating Income | $93.07MM | $66.32MM | $37.43MM |
| Non-Operating Income | $9.38MM | $10.03MM | $4.09MM |
| Interest Expense | $0.26MM | $0.28MM | $0.84MM |
| R&D Expense | $11.45MM | $0.00MM | $0.00MM |
| Income(Loss) | $102.45MM | $76.35MM | $41.53MM |
| Taxes | $38.66MM | $34.29MM | $30.05MM |
| Net Income(Loss)* | $63.79MM | $42.03MM | $10.04MM |
| Stockholders Equity | $497.20MM | $532.11MM | $533.10MM |
| Inventory | $61.45MM | $69.73MM | $102.61MM |
| Assets | $632.76MM | $748.19MM | $742.91MM |
| Operating Cash Flow | $70.64MM | $60.99MM | $22.35MM |
| Capital expenditure | $14.49MM | $10.07MM | $13.82MM |
| Investing Cash Flow | $-11.97MM | $-213.09MM | $-10.12MM |
| Financing Cash Flow | $-14.24MM | $9.55MM | $-40.60MM |
| Earnings Per Share** | $3.31 | $2.20 | $0.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.